These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32561058)

  • 1. The importance of optimal ROIs delineation for FBPA-PET before BNCT.
    Lo YW; Lee JC; Hu YS; Li CY; Chen YL; Lin CS; Huang WS; Lin KH; Chen YW
    Appl Radiat Isot; 2020 Sep; 163():109219. PubMed ID: 32561058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
    Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
    Havu-Aurén K; Kiiski J; Lehtiö K; Eskola O; Kulvik M; Vuorinen V; Oikonen V; Vähätalo J; Jääskeläinen J; Minn H
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):87-94. PubMed ID: 16896669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Borono-2-
    Ishiwata K
    Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
    Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of ZTE-based MR attenuation correction compared to CT-AC in
    Lo YW; Lin KH; Lee CY; Li CW; Lin CY; Chen YW; Wang LW; Wu YH; Huang WS
    Sci Rep; 2024 Jun; 14(1):13950. PubMed ID: 38886395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive estimation of
    Yoshimoto M; Honda N; Kurihara H; Hiroi K; Nakamura S; Ito M; Shikano N; Itami J; Fujii H
    Cancer Sci; 2018 May; 109(5):1617-1626. PubMed ID: 29498142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
    J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the total distribution volume of
    Romanov V; Isohashi K; Alobthani G; Beshr R; Horitsugi G; Kanai Y; Naka S; Watabe T; Shimosegawa E; Hatazawa J
    Ann Nucl Med; 2020 Mar; 34(3):155-162. PubMed ID: 31808134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar T/N ratio between
    Lin YC; Chou FI; Yang BH; Chang CW; Chen YW; Hwang JJ
    Ann Nucl Med; 2020 Jan; 34(1):58-64. PubMed ID: 31650410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model.
    Lin YC; Hwang JJ; Wang SJ; Yang BH; Chang CW; Hsiao MC; Chou FI
    Anticancer Res; 2012 Jul; 32(7):2657-64. PubMed ID: 22753723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas.
    Takahashi Y; Imahori Y; Mineura K
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5888-95. PubMed ID: 14676111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Imaging Technique for Boron Neutron Capture Therapy.
    Fukumitsu N; Matsumoto Y
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [
    Watanabe T; Hattori Y; Ohta Y; Ishimura M; Nakagawa Y; Sanada Y; Tanaka H; Fukutani S; Masunaga SI; Hiraoka M; Ono K; Suzuki M; Kirihata M
    BMC Cancer; 2016 Nov; 16(1):859. PubMed ID: 27821116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of
    Shimosegawa E; Isohashi K; Naka S; Horitsugi G; Hatazawa J
    Ann Nucl Med; 2016 Dec; 30(10):749-755. PubMed ID: 27586407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the applicability of [
    Grunewald C; Sauberer M; Filip T; Wanek T; Stanek J; Mairinger S; Rollet S; Kudejova P; Langer O; Schütz C; Blaickner M; Kuntner C
    Nucl Med Biol; 2017 Jan; 44():83-89. PubMed ID: 27837726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of boron after intravenous 4-dihydroxyborylphenylalanine-fructose (BPA-F) infusion in meningioma and schwannoma patients: A feasibility study for boron neutron capture therapy.
    Kulvik M; Kallio M; Laakso J; Vähätalo J; Hermans R; Järviluoma E; Paetau A; Rasilainen M; Ruokonen I; Seppälä M; Jääskeläinen J
    Appl Radiat Isot; 2015 Dec; 106():207-12. PubMed ID: 26298436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.